Peripheral Neuropathy Instruments for Individuals with Cancer: A COSMIN-Based Systematic Review of Measurement Properties
Although the literature on patient-reported outcomes (PROMs) continues to expand, challenges persist in selecting reliable and valid instruments for assessing peripheral neuropathy (PN) in patients with cancer. This systematic review aimed to identify all validated self-report PN scales and critical...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-12-01
|
| Series: | Current Oncology |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1718-7729/31/12/577 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850241143592189952 |
|---|---|
| author | Silvia Belloni Arianna Magon Chiara Giacon Francesca Savioni Gianluca Conte Rosario Caruso Cristina Arrigoni |
| author_facet | Silvia Belloni Arianna Magon Chiara Giacon Francesca Savioni Gianluca Conte Rosario Caruso Cristina Arrigoni |
| author_sort | Silvia Belloni |
| collection | DOAJ |
| description | Although the literature on patient-reported outcomes (PROMs) continues to expand, challenges persist in selecting reliable and valid instruments for assessing peripheral neuropathy (PN) in patients with cancer. This systematic review aimed to identify all validated self-report PN scales and critically appraise their measurement properties. This review was conducted using the COSMIN methodology for PROMs and the PRISMA statement. Five databases were searched from inception to August 2024, identifying 46 eligible studies and 16 PROMs. Evidence quality ranged from “very low” to “moderate”, with notable inconsistencies in the content and structural validity phases of most instruments. Instruments such as the Chemotherapy-induced peripheral neuropathy assessment tool and the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group–Neurotoxicity demonstrated moderate quality and potential utility in clinical practice, while others, including the Location-based assessment of sensory symptoms in cancer and the Measure of Ovarian Symptoms and Treatment, had insufficient evidence to support their use. Importantly, all PROMs focused on chemotherapy-induced peripheral neuropathy, highlighting a significant gap in instruments addressing other PN causes, such as radiotherapy or tumor-related nerve damage. Further research should prioritize developing and validating instruments for distinct cancer populations, ensuring robust psychometric properties and clinical applicability. |
| format | Article |
| id | doaj-art-e61d5bfb71cd4ff5b485d2cc168dfb68 |
| institution | OA Journals |
| issn | 1198-0052 1718-7729 |
| language | English |
| publishDate | 2024-12-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Current Oncology |
| spelling | doaj-art-e61d5bfb71cd4ff5b485d2cc168dfb682025-08-20T02:00:41ZengMDPI AGCurrent Oncology1198-00521718-77292024-12-0131127828785110.3390/curroncol31120577Peripheral Neuropathy Instruments for Individuals with Cancer: A COSMIN-Based Systematic Review of Measurement PropertiesSilvia Belloni0Arianna Magon1Chiara Giacon2Francesca Savioni3Gianluca Conte4Rosario Caruso5Cristina Arrigoni6Department of Public Health, Experimental and Forensic Medicine, Section of Hygiene, University of Pavia, 27100 Pavia, ItalyHealth Professions Research and Development Unit, IRCCS Policlinico San Donato, San Donato Milanese, 20097 Milan, ItalyFondazione IRCCS Policlinico San Matteo, 27100 Pavia, ItalyIRCCS Humanitas Research Hospital, Rozzano, 20089 Milan, ItalyHealth Professions Research and Development Unit, IRCCS Policlinico San Donato, San Donato Milanese, 20097 Milan, ItalyHealth Professions Research and Development Unit, IRCCS Policlinico San Donato, San Donato Milanese, 20097 Milan, ItalyDepartment of Public Health, Experimental and Forensic Medicine, Section of Hygiene, University of Pavia, 27100 Pavia, ItalyAlthough the literature on patient-reported outcomes (PROMs) continues to expand, challenges persist in selecting reliable and valid instruments for assessing peripheral neuropathy (PN) in patients with cancer. This systematic review aimed to identify all validated self-report PN scales and critically appraise their measurement properties. This review was conducted using the COSMIN methodology for PROMs and the PRISMA statement. Five databases were searched from inception to August 2024, identifying 46 eligible studies and 16 PROMs. Evidence quality ranged from “very low” to “moderate”, with notable inconsistencies in the content and structural validity phases of most instruments. Instruments such as the Chemotherapy-induced peripheral neuropathy assessment tool and the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group–Neurotoxicity demonstrated moderate quality and potential utility in clinical practice, while others, including the Location-based assessment of sensory symptoms in cancer and the Measure of Ovarian Symptoms and Treatment, had insufficient evidence to support their use. Importantly, all PROMs focused on chemotherapy-induced peripheral neuropathy, highlighting a significant gap in instruments addressing other PN causes, such as radiotherapy or tumor-related nerve damage. Further research should prioritize developing and validating instruments for distinct cancer populations, ensuring robust psychometric properties and clinical applicability.https://www.mdpi.com/1718-7729/31/12/577peripheral neuropathyvalidityreliabilityinstrumentspatient-reported outcome measurePROMs |
| spellingShingle | Silvia Belloni Arianna Magon Chiara Giacon Francesca Savioni Gianluca Conte Rosario Caruso Cristina Arrigoni Peripheral Neuropathy Instruments for Individuals with Cancer: A COSMIN-Based Systematic Review of Measurement Properties Current Oncology peripheral neuropathy validity reliability instruments patient-reported outcome measure PROMs |
| title | Peripheral Neuropathy Instruments for Individuals with Cancer: A COSMIN-Based Systematic Review of Measurement Properties |
| title_full | Peripheral Neuropathy Instruments for Individuals with Cancer: A COSMIN-Based Systematic Review of Measurement Properties |
| title_fullStr | Peripheral Neuropathy Instruments for Individuals with Cancer: A COSMIN-Based Systematic Review of Measurement Properties |
| title_full_unstemmed | Peripheral Neuropathy Instruments for Individuals with Cancer: A COSMIN-Based Systematic Review of Measurement Properties |
| title_short | Peripheral Neuropathy Instruments for Individuals with Cancer: A COSMIN-Based Systematic Review of Measurement Properties |
| title_sort | peripheral neuropathy instruments for individuals with cancer a cosmin based systematic review of measurement properties |
| topic | peripheral neuropathy validity reliability instruments patient-reported outcome measure PROMs |
| url | https://www.mdpi.com/1718-7729/31/12/577 |
| work_keys_str_mv | AT silviabelloni peripheralneuropathyinstrumentsforindividualswithcanceracosminbasedsystematicreviewofmeasurementproperties AT ariannamagon peripheralneuropathyinstrumentsforindividualswithcanceracosminbasedsystematicreviewofmeasurementproperties AT chiaragiacon peripheralneuropathyinstrumentsforindividualswithcanceracosminbasedsystematicreviewofmeasurementproperties AT francescasavioni peripheralneuropathyinstrumentsforindividualswithcanceracosminbasedsystematicreviewofmeasurementproperties AT gianlucaconte peripheralneuropathyinstrumentsforindividualswithcanceracosminbasedsystematicreviewofmeasurementproperties AT rosariocaruso peripheralneuropathyinstrumentsforindividualswithcanceracosminbasedsystematicreviewofmeasurementproperties AT cristinaarrigoni peripheralneuropathyinstrumentsforindividualswithcanceracosminbasedsystematicreviewofmeasurementproperties |